Jabil Healthcare, a division of Jabil Inc., is collaborating with global drug delivery device company E3D, a member of the Elcam Medical Group. The agreement gives Jabil access to E3D’s reusable mechanical auto-injector and exclusive rights to develop a high-volume reusable auto-injector and connected variants, it was reported in a news release.

“Our collaboration with E3D enhances Jabil’s development of pharmaceutical solutions that move us into the future of connected, digital devices that are more intuitive, economical, and sustainable,” said James O’Gorman, vice president, Pharmaceutical Delivery Systems (PDS), Jabil Healthcare, in the release. “This is an exciting expansion of our relationship with E3D that will benefit our market offering and healthcare customers alike.”

Added Tsachi Shaked, general manager of E3D: “As a leader in the healthcare arena, Jabil Healthcare is the perfect partner for us and for a drug delivery market that requires the highest levels of competence, experience, and scale in manufacturing. Our complementary expertise in electronics, manufacturing, and data analysis is the type of collaboration that should help speed advances and adoption of digital health technologies.”

Together, Jabil Healthcare and E3D offer pre-launch support, including full global commercial supply, lifecycle management, final product assembly, labeling, and manufacturing services.